Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,407 $ 6,830
Marketable debt securities 11,809 21,933
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 1,723 5,719
Total current assets 19,989 34,532
Non-current assets:    
Leasehold improvements and equipment – net 2,021 2,091
Operating lease right-of-use assets – net 3,206 3,613
Finance lease right-of-use assets – net 22 30
In-process research and development 3,017 3,017
Goodwill 1,336 1,336
Restricted cash – security deposit 200 200
Total non-current assets 9,802 10,287
Total assets 29,791 44,819
Current liabilities:    
Accounts payable 835 618
Accrued expenses 1,757 3,099
Operating lease liabilities – current 632 562
Financing lease liabilities – current 5 7
Total current liabilities 3,229 4,286
Non-current liabilities:    
Deferred tax liability 341 341
Operating lease liabilities – net of current portion 3,052 3,533
Financing lease liabilities – net of current portion 19 22
Total non-current liabilities 3,412 3,896
Total liabilities 6,641 8,182
Stockholders’ equity:    
Common stock par value $0.0001 per share, 500,000,000 shares authorized at September 30, 2023 and December 31, 2022; 217,264,526 issued and outstanding as of September 30, 2023 and December 31, 2022 22 22
Additional paid-in capital 193,746 190,070
Accumulated deficit (170,259) (152,631)
Accumulated other comprehensive loss (359) (824)
Total stockholders’ equity 23,150 36,637
Total liabilities and stockholders’ equity $ 29,791 $ 44,819